VacZine Analytics  
What we do
The mission of VacZine Analytics is simple. We seek to enable vaccine clients to make better-informed decisions.

We produce a range of syndicated research products to support broad day-to-day activities such as:

» Disease analysis - identification of key trends, issues and dynamics
» Building new business - new product strategy/R&D prioritization
» Growing existing business - lifecycle management opportunities
» Finding new business - commercial due diligence/horizon scanning
» Planning the future - strategic planning/internal consultation

Please request our company brochure

What do our clients say?
We have established productive relationships with major clients. Read their feedback.....

Client feedback

In the Press
Find out about VacZine Analytics contribution to major journal and press articles:

» Sheridan C. Vaccine Market Boosters, Nature Biotechnology. June 2009, Volume 27 No 6 pp502-578

» Schomann-Finck C. Neue Euphorie. Money Maker. Focus Money Magazine (German), Issue 26, 2009

» Lucero CA., et al. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine. 2009 - In Press

» Sheridan C. Will J&J turbocharge Crucell's vaccine portfolio? Nature Biotechnology. December 2010, Volume 28 No 12 pp1223-1224

© 2011 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains